ImaCor hTEE Technology Studied For Future Space Missions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GARDEN CITY, N.Y.--(BUSINESS WIRE)--ImaCor, Inc., the developer of the world’s first and only hemodynamic transesophageal echocardiography (hTEE™) technology, announced that hTEE was tested in microgravity through NASA’s Reduced Gravity Education Flight Program. Stanford University (Stanford, CA) students chose to study hTEE’s functionality and usability in space conditions to explore the possibilities for hemodynamic monitoring in spaceflight missions. Cardiothoracic surgeon Peter H.U. Lee MD, MPH, MS, currently at The Ohio State University Wexner Medical Center, served as faculty advisor.

Help employers find you! Check out all the jobs and post your resume.

Back to news